Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy

Mateusz Śpiewak1, Mariusz Kłopotowski2, Łukasz Mazurkiewicz3

  • 1Magnetic Resonance Unit, Department of Radiology, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland. mspiewak@ikard.pl.

Scientific Reports
|December 4, 2020
PubMed

Insights

Right ventricular (RV) function in hypertrophic cardiomyopathy (HCM) is linked to left ventricular (LV) function and size. RV systolic dysfunction is uncommon in HCM but associated with impaired LV function and impacts RV size.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Hypertrophic Cardiomyopathy

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary disease of the left ventricle (LV).
  • The impact of HCM on right ventricular (RV) function and size requires further investigation.
  • Understanding RV involvement is crucial for comprehensive HCM patient management.

Purpose of the Study:

  • To investigate factors associated with RV function and size in patients with HCM.
  • To identify predictors of RV ejection fraction (RVEF) and RV end-diastolic volume (RVEDV) in HCM.
  • To explore the relationship between RV hypertrophy and sudden cardiac death (SCD) risk in HCM.

Main Methods:

  • Cardiac magnetic resonance (CMR) imaging in 253 HCM patients and 20 healthy volunteers.
  • Assessment of RV and LV function (ejection fraction), size (end-diastolic volume), and hypertrophy (wall thickness).
  • Analysis of late gadolinium enhancement (LGE) in both ventricles and correlation with clinical parameters.

Main Results:

  • HCM patients showed higher RVEF and lower RVEDV than controls, with increased mean RV wall thickness.
  • Left ventricular ejection fraction (LVEF), LV outflow tract gradient, LV LGE, maximal LV wall thickness, and tricuspid regurgitation (TR) volume predicted RVEF.
  • LVEF and TR volume were independent predictors of RVEF < 45%.
  • LVEDV and TR volume predicted RVEDV, while RVEF, RV wall thickness, LV LGE, and age were negative predictors.
  • RV systolic dysfunction (low RVEF) was uncommon and linked to poor LV systolic function.
  • A weak positive association was found between RV hypertrophy and 5-year SCD probability.

Conclusions:

  • RV systolic dysfunction is infrequent in HCM and strongly associated with impaired LV systolic function.
  • LV characteristics significantly influence RV size and function in HCM patients.
  • CMR is valuable for assessing RV involvement and its predictors in HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
182
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
341
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
186
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
258
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204